In a powerful step toward revolutionizing women’s health, eSense Health Inc. has announced the results of a pivotal clinical trial proving the effectiveness of its digital therapy platform, eSense, in treating Female Sexual Interest/Arousal Disorder (SIAD)—a condition that impacts up to 40% of women.
Published in the respected peer-reviewed journal Behaviour Research & Therapy, this trial marks a significant milestone in how sexual wellness can be treated—privately, affordably, and effectively—especially for those suffering in silence.
Why eSense Matters: Addressing a Widespread Yet Silent Issue
Sexual health is deeply connected to a woman’s overall well-being, yet it’s often neglected. Conditions like SIAD—marked by low desire, difficulty in arousal, or distress during intimacy—are incredibly common. Yet, less than 20% of affected women receive any form of treatment.
Why the gap? It stems from a mix of social stigma, limited awareness, long waitlists, and a lack of trained professionals. Even in modern medicine, sexual health remains under-discussed, and most physicians receive minimal training in this area. eSense steps in to bridge this critical gap—offering care where traditional systems have failed.
The Power Behind eSense: CBT and MBT in a Digital Format
eSense delivers two types of evidence-based therapies:
Cognitive Behavioral Therapy (CBT) Mindfulness-Based Therapy (MBT)
Both are widely recognized psychological treatments. What makes eSense unique is its interactive, self-guided delivery system, allowing women to complete therapy at home, on their terms, and at a fraction of the cost of in-person sessions.
These modules aren’t generic. They’re crafted specifically for women dealing with SIAD and include practical tools to address low sexual desire, emotional distress, and the psychological factors that often go unspoken.
Clinical Trial Results: Digital Therapy That Really Works
The recent randomized clinical trial included 129 women diagnosed with SIAD across Canada and the U.S. Participants were divided into three groups—one received the CBT program, another MBT, and a third was placed on a waitlist.
